The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aquestive Therapeutics Inc shares valued at $300,000 were sold by Schobel Alexander Mark on Mar 15 ’24. At $6.00 per share, Schobel Alexander Mark sold 50,000 shares. The insider’s holdings dropped to 984,476 shares worth approximately $4.04 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Schobel Alexander Mark sold 25,000 shares, netting a total of over 129,685 in proceeds. Following the sale of shares at $5.19 each, the insider now holds 1,040,371 shares.
Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late April. As of January 03, 2019, Lake Street has initiated its “Buy” rating for AQST. Earlier on August 20, 2018, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for AQST stock.
Analyzing AQST Stock Performance
During the last five days, there has been a drop of approximately -8.99%. Over the course of the year, Aquestive Therapeutics Inc shares have jumped approximately 102.97%. Shares of the company reached a 52-week high of $6.23 on 03/18/24 and a 52-week low of $1.95 on 01/02/24. A 50-day SMA is recorded $3.49, while a 200-day SMA reached $2.23. Nevertheless, trading volume fell to 2.41 million shares from 3.56 million shares the previous day.
Support And Resistance Levels for Aquestive Therapeutics Inc (AQST)
According to the 24-hour chart, there is a support level at 3.99, which, if violated, would cause prices to drop to 3.88. In the upper region, resistance lies at 4.21. The next price resistance is at 4.33. RSI (Relative Strength Index) is 47.71 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.75, which suggests the price will decrease in the coming days. Percent R is at 95.09%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Aquestive Therapeutics Inc subject to short interest?
Stocks of Aquestive Therapeutics Inc saw a sharp rise in short interest on Feb 29, 2024 jumping by 70000.0 shares to 1.81 million. Data from Yahoo Finance shows that the short interest on Jan 31, 2024 was 1.74 million shares. A jump of 3.87% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.34 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.34.
